Neuralink's 'Blindsight' Device Receives FDA Breakthrough Designation

Elon Musk’s brain-chip company Neuralink has received the FDA's “breakthrough device” designation for its experimental vision-restoring implant, Blindsight.  The designation, announced on Tuesday, September 17, did not specify a timeline for human trials. However, with the device now classified as a “breakthrough device,” it is eligible for expedited review by the FDA, which could accelerate […]

The post Neuralink’s ‘Blindsight’ Device Receives FDA Breakthrough Designation appeared first on Techopedia.